Research

Joseph Arboleda-Velasquez, MD, PhD, Awarded $500,000 in Funding to Support Alzheimer's Research

February 8, 2022

Dr. Joe ArboledaJoseph Arboleda-Velasquez, MD, PhD, Assistant Professor of Ophthalmology at Harvard Medical School (HMS) and Assistant Scientist at Schepens Eye Research Institute of Mass Eye and Ear, is a 2022 recipient of the Edward N. & Della L. Thome Memorial Foundation Awards Program in Alzheimer's Disease Drug Discovery Research.... Read more about Joseph Arboleda-Velasquez, MD, PhD, Awarded $500,000 in Funding to Support Alzheimer's Research

Joseph F. Arboleda-Velásquez, MD, PhD, Receives $4 Million Research Gift

September 29, 2020

Dr. Joseph F. Arboleda-Velásquez in his laboratory

Joseph F. Arboleda-Velasquez, MD, PhD, an Assistant Professor of Ophthalmology at Harvard Medical School and assistant scientist at Mass Eye and Ear who studies small vessel disease in the brain and the eye, has been awarded a five-year, $4 million gift from Good Ventures to spur his lab’s groundbreaking work into Alzheimer’s disease genetic resistance.... Read more about Joseph F. Arboleda-Velásquez, MD, PhD, Receives $4 Million Research Gift

Researchers Uncover Mechanism for How Common Gene Therapy Vectors Enter Cells

January 24, 2020

Luk Vandenberghe

Researchers led by a team at Massachusetts Eye and Ear have identified a novel cellular entry factor for adeno-associated virus vector (AAV) types—the most commonly used viral vectors for in vivo gene therapy. AAVs are vectors–or vehicles—that are created from a virus that is made harmless by molecular engineering, and have shown promise transporting genetic therapy treatments to affected tissues.... Read more about Researchers Uncover Mechanism for How Common Gene Therapy Vectors Enter Cells

Joan W. Miller Part of Expert Panel that Recommends Strategy Shift to Discover Dry AMD Treatments

July 26, 2019

A large-scale, collaborative, systems biology approach is needed to expedite the discovery of treatments for dry age-related macular degeneration, according to a report by a working group of scientists appointed by the National Advisory Eye Council (NAEC) that includes Joan. W. Miller, MD, Chair of Harvard Ophthalmology.

... Read more about Joan W. Miller Part of Expert Panel that Recommends Strategy Shift to Discover Dry AMD Treatments

Researchers Identify Metabolomics as a Potential Tool to Improve Diagnostic and Prognostic Information on AMD

July 9, 2019

A recent meta-analysis, led by Deeba Husain, MD, suggests that AMD patients present distinct plasma metabolomic profiles, which vary with disease severity. After analyzing blood samples of their 491 patients from two cohorts–one in Boston and one in Coimbra, Portugal–they found that metabolites differed significantly between AMD patients as compared to controls, and with various stages of the disease.... Read more about Researchers Identify Metabolomics as a Potential Tool to Improve Diagnostic and Prognostic Information on AMD

Mass. Eye and Ear Research Team Link Immune Cells to Uveitis

April 30, 2019

New research led by Kip Connor, PhD, finds that microglia—the primary immune cells of the central nervous system, including the retina—play a vital role in regulating neuroinflammation in autoimmune uveitis. The study, published in Proceedings of the National Academy of Sciences and featured on eyewire News, may one day lead to better treatment targets for the disease.

In the preclinical model of autoimmune uveitis, the researchers describe, for the first time, a role for microglia in directing the initiation of autoimmune uveitis by orchestrating the inflammatory response within the retina. In reaction to disease induction, microglia closely associate with the retinal vasculature and facilitate inflammatory immune cell entry past the blood brain, or ocular, barrier into the retina. When the researchers depleted microglia in this model, they observed that the disease was completely blocked.

... Read more about Mass. Eye and Ear Research Team Link Immune Cells to Uveitis

Study Led by Michael Gilmore, PhD, Identifies Pathway for how Enterococcus Faecalis Bacteria Causes Antibiotic-Resistant Infection

April 18, 2019

A new study led by a research team from Harvard Medical School and Mass. Eye and Ear, describes how bacteria adapted to the modern hospital environment and repeatedly cause antibiotic-resistant bloodstream infections. This study examined one of the first sustained hospital outbreaks of a multidrug-resistant bacterium, Enterococcus faecalis, which occurred from the early through the mid-1980s, causing over 60 outbreak strains.... Read more about Study Led by Michael Gilmore, PhD, Identifies Pathway for how Enterococcus Faecalis Bacteria Causes Antibiotic-Resistant Infection

Pages